期刊文献+

高效液相色谱法测定人血浆盐酸特比萘芬浓度 被引量:3

Determination of Terbinafine Hydrochloride in Human Plasma by HPLC
下载PDF
导出
摘要 目的建立测定人血浆盐酸特比萘芬浓度的高效液相色谱法。方法以利洛司酮作内标,三氯甲烷为提取溶剂,色谱柱Acclaim C18柱(250 mm×4.6 mm,5μm),流动相为甲醇-乙腈-0.01 mol.L-1磷酸二氢钾缓冲液(pH值3.9)(5:45:50),流速1.0 mL.min-1。检测波长224 nm。结果血浆盐酸特比萘芬浓度在0.04~2.40 mg.L-1范围内线性关系良好,加权最小二乘法进行回归运算得回归方程为C=0.003 2Y+0.051 3,相关系数r=0.998 6(n=7),最低检测浓度为0.04 mg.L-1。方法回收率为99.2%~102.5%,日内RSD<12%,日间RSD<8%。结论该方法操作简便,灵敏度高,重复性好,能快速准确测定人血浆盐酸特比萘芬浓度。 Objective To establish a method for determining concentration of terbinafine hydrochloride in human plasma by HPLC. Methods Lilopristone was chosen as the internal standard. Chloroform was used for extraction. Acclaim C18 column (250 mm × 4.6 mm,5 μm)was used and the mobile phase was composed of methanol -acetonitrile-0.01 mol ·L^-1 potassium dihydrogen phosphate buffer (pH 3.9) (5 : 45 : 50) ,eluted at a flow rate of 1.0 mL ·min^-1. UV detection wavelength was set at 224 nm Results A good linear calibration curves was obtained at the range of 0.04 - 2.40 mg ·L^-1. The regression equation was C = 0.003 2 Y + 0. 051 3 ,r = 0.998 6 (n = 7 ) calculated by least square method. The detection limit was 0.04 mg ·L^-1 and the recovery was 99.2% - 102.5% with intra-day RSD less than 12% and inter-day RSD less than 8%. Conclusion This method is simple, sensitive, accurate and reproducible for concentration determination of terbinafine hydrochloride in plasma.
出处 《医药导报》 CAS 2009年第12期1543-1545,共3页 Herald of Medicine
关键词 特比萘芬 盐酸 色谱法 高效液相 血药浓度 Terbinafine, hydrochloride HPLC Plasma drug concentration
  • 相关文献

参考文献5

二级参考文献28

  • 1冀学芳,于魁一.盐酸特比萘芬片剂的溶出度及含量测定方法研究[J].药物分析杂志,1995,15(A01):286-288. 被引量:1
  • 2李涌波,于力,单红宾.高效液相色谱法测定盐酸特比萘芬的含量[J].沈阳药科大学学报,1996,13(2):141-142. 被引量:6
  • 3汪洁.特比萘芬及片剂的紫外分光光度测定[J].中国医药工业杂志,1996,27(8):363-365. 被引量:3
  • 4Doczi l, Gyetvai T, Kredics L,et al. Involvement of Fusafium spp. in fungal keratitis [J]. Clin Microbiol Infect, 2004,10:773 - 776.
  • 5Kohler LM, Monteiro PC, Hahn RC, et al. In vitro susceptibilities of isolates of sporothrix schenckii to itraconazole and terbinafine [J]. J Clin Microbiol,2004,42: 4319 - 4320.
  • 6Karaarslan A, Arikan S, Ozcan M,et al, In vitro activity of terbinafine and itraconazole against Aspergillus species isolated from otomycosis [J].Mycoses ,2004,47: 284 - 287.
  • 7McGinnis MR, Nordoff NG, Ryder NS, et al. In vitro comparison of terbinafine and itraconazole against penicillium marneffei [J]. Antimicrob Agents Chemother,2000,44 : 1407 - 14.78.
  • 8Yeganeh MH, McLachlan AJ. Determination of terbinafine in tissues [J].Biomed Chromatogr,2000,14: 261 -268.
  • 9Dykes PJ, Thomas R, Finlay AY. Determination of terbinafine in nail samples during systemic treatment for onychomycoses [J]. Br J Dermatol,1990,123:481 -486.
  • 10Anderson KL, Mitra S, Salouti R, et al. Fungal keratitis caused by Paecilomyces lilacinus associated with a retained intracomeal hair [J].Cornea,2004,23: 516 - 521.

共引文献22

同被引文献13

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部